News and events of Sobhan Oncology Company

After successful registration of Everolimus tablets in Syria, Sobhan Oncology Pharmaceutical Company was able to send the first part of its export order to Syria. This export shipment was dispatched…

In line with the goals and fulfillment of its export plans, Sobhan Oncology Pharmaceutical Company managed to send the first export shipment to Bolivia. The CEO of Sobhan Oncology Company…

The export shipment of paclitaxel 300 mg of Sobhan Oncology was exported to Iraq on July 14, 1402. Sobhan Oncology Pharmaceutical Company, as the largest oncology product manufacturer site in…

The first export shipment of Cisplatin 50 mg, produced by Sobhan Oncology Company was sent to Iraq. This export shipment was exported to Iraq on 03/06/2023 with specialized Arabic-English artworks.

Sobhan Oncology Pharmaceutical Company exported more than 30,000 packages of anti-cancer drug “Gemcitabine” to Iraq, as part of a contractual agreement with an Iraqi pharmaceutical company. The export permits for…

In the year 2022, Sobhan Oncology Pharmaceutical Company achieved the fourth rank in terms of exports among all pharmaceutical companies that are members of the Syndicate of the Owners of…